These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25776511)

  • 41. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.
    Hu H; Li Y; Zhou Q; Ao Y; Yu C; Wan Y; Xu H; Li Z; Yang X
    ACS Appl Mater Interfaces; 2016 Nov; 8(45):30833-30844. PubMed ID: 27791359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of doxorubicin α-linolenic acid conjugate and evaluation of its antitumor activity.
    Liang CH; Ye WL; Zhu CL; Na R; Cheng Y; Cui H; Liu DZ; Yang ZF; Zhou SY
    Mol Pharm; 2014 May; 11(5):1378-90. PubMed ID: 24720787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
    Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
    J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
    Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA
    J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
    Wu G; Wang Z; Bian X; Du X; Wei C
    Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.
    Aroui S; Brahim S; Waard MD; Kenani A
    Biochem Biophys Res Commun; 2010 Jan; 391(1):419-25. PubMed ID: 19914216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted delivery of doxorubicin: drug delivery system based on PAMAM dendrimers.
    Yabbarov NG; Posypanova GA; Vorontsov EA; Popova ON; Severin ES
    Biochemistry (Mosc); 2013 Aug; 78(8):884-94. PubMed ID: 24228876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW
    Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
    Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
    Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
    Bae M; Cho S; Song J; Lee GY; Kim K; Yang J; Cho K; Kim SY; Byun Y
    Drugs Exp Clin Res; 2003; 29(1):15-23. PubMed ID: 12866360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics.
    Li Z; Zhao R; Wu X; Sun Y; Yao M; Li J; Xu Y; Gu J
    FASEB J; 2005 Dec; 19(14):1978-85. PubMed ID: 16319141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
    Dong DW; Tong SW; Qi XR
    J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poly(2-ethyl-2-oxazoline)-doxorubicin conjugate-based dual endosomal pH-sensitive micelles with enhanced antitumor efficacy.
    Li J; Zhou Y; Li C; Wang D; Gao Y; Zhang C; Zhao L; Li Y; Liu Y; Li X
    Bioconjug Chem; 2015 Jan; 26(1):110-9. PubMed ID: 25506713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
    Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
    Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.